TRIMU 5

TRIMU 5
	L-tyrosyl-N[(3-methylbutyl)amino]acetylD-alaninamide
Drugi nazivi	(2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1[2-(3-methylbutylamino)acetyl]amino1-oxopropan-2-yl]propanamide
Identifikacija
CAS registarski broj	90815-77-3
PubChem	5487273
ChemSpider	21106389
Jmol-3D slike	Slika 1
SMILES
	Oc1ccc(C[C@@H](N)C(=O)N[C@H](C)C(=O)NC(=O)CNCCC(C)C)cc1
InChI
	InChI=1S/C19H30N4O4/c1-12(2)8-9-21-11-17(25)23-18(26)13(3)22-19(27)16(20)10-14-4-6-15(24)7-5-14/h4-7,12-13,16,21,24H,8-11,20H2,1-3H3,(H,22,27)(H,23,25,26)/t13-,16?/m1/s1 ; Kod: QOGVSHVPIMZZRN-JBZHPUCOSA-N InChI=1/C19H30N4O4/c1-12(2)8-9-21-11-17(25)23-18(26)13(3)22-19(27)16(20)10-14-4-6-15(24)7-5-14/h4-7,12-13,16,21,24H,8-11,20H2,1-3H3,(H,22,27)(H,23,25,26)/t13-,16?/m1/s1; Kod: QOGVSHVPIMZZRN-JBZHPUCOBN
Svojstva
Molekulska formula	C19H30N4O4
Molarna masa	378.466
	(šta je ovo?) (verifikuj) ; Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
	Infobox references

TRIMU 5 je selektivni μ2-agonist/μ1-antagonist mi opioidnog receptora. On stimuliše hipotalamo-hipofizno-adrenalnu osu.^[4]^[5] U eksprerimentima na pacovima TRIMU-5, 50 μg, proizvodi održiv porast kortikosterona u plazmi u toku tročasovnog perioda. Niže doze (10 μg) ne proizvode respons, dok veće doze (100 μg) povišavaju hormonski odgovor, ali su letalne u 50% slučajeva.^[4]

Literatura[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ ^4,0 ^4,1 Eisenberg RM (1994). „TRIMU-5, a mi 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis”. Pharmacol. Biochem. Behav. 47 (4): 943–6. DOI:10.1016/0091-3057(94)90300-X. PMID 8029266.
↑ Tive LA, Pick CG, Paul D, Roques BP, Gacel GA, Pasternak GW. (1992). „Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist”. Eur J Pharmacol. 216 (2): 249-55. PMID 1327812.

Spoljašnje veze[uredi | uredi kod]

Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[pmid8029266-4] 4,0 ^4,1 Eisenberg RM (1994). „TRIMU-5, a mi 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis”. Pharmacol. Biochem. Behav. 47 (4): 943–6. DOI:10.1016/0091-3057(94)90300-X. PMID 8029266.

[pmid1327812-5] Tive LA, Pick CG, Paul D, Roques BP, Gacel GA, Pasternak GW. (1992). „Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist”. Eur J Pharmacol. 216 (2): 249-55. PMID 1327812.

[1]

[2]

[3]

[4]

[5]

TRIMU 5

Literatura[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]

Navigacija

Pretraga